已关闭
  • 顶部Banner位
  • 固定模块
设置
BPD
试用
AI
企业管理端
厂家
TMEM173基因敲除细胞池(LX-2)
收藏 收藏
分享
原料试剂 研发实验室
价格
¥5499.00
品牌 粒曼生物
地区 中国,湖北省,武汉市
货号 LM01074184584
产地 国产
选择规格
1×10^6 cells/ 冻存管
易享客服
粒曼生物科技(武汉)有限公司
粒曼生物科技(武汉)有限公司
中国湖北武汉
营业执照已审核
粒曼生物专注于提供高通量细胞编辑解决方案,服务新药研发与基础科研。 粒曼生物是一家专注于高通量细胞编辑工具研发的技术驱动型公司,核心技术来自加州大学伯克利分校,公司已完成人全基因组19883个基因的敲除实验验证。基于粒曼工业智能化高通量体外细胞编辑平台,为客户提供基因敲除、过表达、点突变、原位/定点敲入定制服务及基因编辑细胞现货、基因敲除试剂盒等系列产品,助力新药研发与基础研究。 粒曼作为国内高通量基因敲除阵列文库领域的领导者,已建成自动化、高通量基因敲除平台,实现每月1000+ KO 细胞的生产产能。粒曼基于自身构建的 Harbor 细胞和 pCargo 质粒载体系统,实现 2 周高效构建稳定细胞系。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
粒曼生物
货号
LM01074184584
国产/进口
国产
规格
1×10^6 cells/ 冻存管
货源
新品
图文详情

细胞基因敲除效率:82%

TMEM173 NCBI Gene ID:340061

TMEM173 Ensembl ID:ENSG00000184584

TMEM173 Uniprot ID:Q86WV6

TMEM173 基因介绍:(Microbial infection) Antiviral activity is antagonized by oncoproteins, such as papillomavirus (HPV) protein E7 and adenovirus early E1A protein (PubMed:26405230). Such oncoproteins prevent the ability to sense cytosolic DNA (PubMed:26405230).||Facilitator of innate immune signaling that acts as a sensor of cytosolic DNA from bacteria and viruses and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:18724357, PubMed:18818105, PubMed:19433799, PubMed:19776740, PubMed:23027953, PubMed:23910378, PubMed:23747010, PubMed:30842659). Innate immune response is triggered in response to non-CpG double-stranded DNA from viruses and bacteria delivered to the cytoplasm (PubMed:26300263). Acts by binding cyclic dinucleotides: recognizes and binds cyclic di-GMP (c-di-GMP), a second messenger produced by bacteria, and cyclic GMP-AMP (cGAMP), a messenger produced by CGAS in response to DNA virus in the cytosol (PubMed:21947006, PubMed:23258412, PubMed:23707065, PubMed:23722158, PubMed:26229117, PubMed:23910378, PubMed:23747010, PubMed:30842659). Upon binding of c-di-GMP or cGAMP, STING1 oligomerizes, translocates from the endoplasmic reticulum and is phosphorylated by TBK1 on the pLxIS motif, leading to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent anti-viral state (PubMed:22394562, PubMed:25636800, PubMed:30842653). In addition to promote the production of type I interferons, plays a direct role in autophagy (PubMed:30568238, PubMed:30842662). Following cGAMP-binding, STING1 buds from the endoplasmic reticulum into COPII vesicles, which then form the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) (PubMed:30842662). The ERGIC serves as the membrane source for WIPI2 recruitment and LC3 lipidation, leading to formation of autophagosomes that target cytosolic DNA or DNA viruses for degradation by the lysosome (PubMed:30842662). The autophagy- and interferon-inducing activities can be uncoupled and autophagy induction is independent of TBK1 phosphorylation (PubMed:30568238, PubMed:30842662). Autophagy is also triggered upon infection by bacteria: following c-di-GMP-binding, which is produced by live Gram-positive bacteria, promotes reticulophagy (By similarity). Exhibits 2',3' phosphodiester linkage-specific ligand recognition: can bind both 2'-3' linked cGAMP (2'-3'-cGAMP) and 3'-3' linked cGAMP but is preferentially activated by 2'-3' linked cGAMP (PubMed:26300263, PubMed:23910378, PubMed:23747010). The preference for 2'-3'-cGAMP, compared to other linkage isomers is probably due to the ligand itself, whichs adopts an organized free-ligand conformation that resembles the STING1-bound conformation and pays low energy costs in changing into the active conformation (PubMed:26150511). May be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons (PubMed:18724357). May be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II) (By similarity).

细胞生长培养基:DMEM+10%FBS+1%Anti-Anti

细胞培养条件:37℃,5% CO2 的培养箱,1/2 到 1/4 传代

细胞倍增时间:~20-24 hours

细胞支原体检测结果:阴性

细胞开发路径:采用CRISPR-RNP方法生成稳定KO Cell Pool;Sanger 测序结果显示KO Cell Pool敲除效率>70%

细胞应用:高敲除效率的基因敲除细胞池(KO Cell Pool),特别适用于初步功能分析、复杂疾病模型的开发、精准药物筛选以及广泛的基因发现研究。

技术文档
没有您想要的资料?去索要
返回顶部